US Stock MarketDetailed Quotes

Benitec Biopharma (BNTC)

Watchlist
  • 12.830
  • +0.710+5.86%
Close Jan 22 16:00 ET
  • 12.830
  • 0.0000.00%
Post 20:01 ET
434.45MMarket Cap-11.77P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Benitec Biopharma (BNTC) Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Sep 30, 2025
(FY)Jun 30, 2025
(Q4)Jun 30, 2025
(Q3)Mar 31, 2025
(Q2)Dec 31, 2024
(Q1)Sep 30, 2024
(FY)Jun 30, 2024
(Q4)Jun 30, 2024
(Q3)Mar 31, 2024
(Q2)Dec 31, 2023
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
26.93%-3.35M
-21.57%-23.59M
-149.41%-8.21M
49.97%-3.09M
-43.58%-7.7M
-0.20%-4.59M
-7.72%-19.4M
19.58%-3.29M
-53.09%-6.17M
8.18%-5.37M
Net income from continuing operations
-77.21%-8.97M
-74.32%-37.92M
-242.10%-16.15M
-118.60%-9.35M
-8.22%-7.36M
15.03%-5.06M
-11.19%-21.75M
-1.27%-4.72M
2.68%-4.28M
-25.63%-6.8M
Depreciation and amortization
29.67%118K
15.45%396K
29.67%118K
17.78%106K
1.25%81K
10.98%91K
-9.97%343K
8.33%91K
-3.23%90K
-21.57%80K
Other non cash items
----
---764K
--0
--0
----
----
----
----
----
----
Change In working capital
696.23%316K
-332.45%-2.73M
-738.89%-5.64M
264.21%3.57M
-148.13%-606K
-104.40%-53K
64.43%1.17M
147.75%882K
-1,185.50%-2.17M
357.46%1.26M
-Change in receivables
-86.73%30K
211.93%197K
83.52%-29K
--0
--0
--226K
-252.00%-176K
---176K
--0
--0
-Change in prepaid assets
56.00%156K
-117.21%-111K
36.45%-258K
-108.78%-18K
-52.55%65K
-85.90%100K
255.80%645K
-1.50%-406K
151.00%205K
-18.45%137K
-Change in payables and accrued expense
152.94%162K
-350.92%-2.46M
-441.53%-5.24M
259.64%3.68M
-150.13%-597K
-154.45%-306K
-31.47%980K
87.07%1.53M
-446.92%-2.31M
318.93%1.19M
-Change in other current liabilities
56.16%-32K
-29.45%-356K
-55.71%-109K
-44.93%-100K
-7.25%-74K
-8.96%-73K
-9.13%-275K
-9.38%-70K
-9.52%-69K
-9.52%-69K
Cash from discontinued investing activities
Operating cash flow
26.93%-3.35M
-21.57%-23.59M
-149.41%-8.21M
49.97%-3.09M
-43.58%-7.7M
-0.20%-4.59M
-7.72%-19.4M
19.58%-3.29M
-53.09%-6.17M
8.18%-5.37M
Investing cash flow
Cash flow from continuing investing activities
89.94%-18K
0
96.65%-6K
-17,800.00%-179K
0
-179K
Net PPE purchase and sale
----
89.94%-18K
--0
96.65%-6K
----
----
-17,800.00%-179K
--0
---179K
----
Cash from discontinued investing activities
Investing cash flow
--0
89.94%-18K
--0
96.65%-6K
---12K
--0
-17,800.00%-179K
--0
---179K
--0
Financing cash flow
Cash flow from continuing financing activities
0
3.61%70.49M
-93.65%2.54M
28.41M
45,720.51%17.87M
-22.43%21.66M
324.78%68.03M
40.07M
0
39K
Net common stock issuance
----
-57.03%30.46M
-100.00%1K
-23,156.41%-9.07M
45,730.77%17.87M
-29.88%21.66M
296.35%70.88M
--40M
---39K
--39K
Proceeds from stock option exercised by employees
--0
1,293.81%42.34M
-12.80%2.62M
----
----
--21.66M
--3.04M
--3M
----
----
Net other financing activities
----
60.64%-2.32M
97.54%-72K
---2.25M
----
----
-215.25%-5.89M
---2.93M
--0
--0
Cash from discontinued financing activities
Financing cash flow
--0
3.61%70.49M
-93.65%2.54M
--28.41M
45,720.51%17.87M
-22.43%21.66M
324.78%68.03M
--40.07M
--0
--39K
Net cash flow
Beginning cash position
92.14%97.86M
1,945.34%50.93M
632.17%103.65M
284.27%78.35M
162.41%67.91M
1,945.34%50.93M
-38.91%2.49M
115.63%14.16M
93.23%20.39M
56.38%25.88M
Current changes in cash
-119.63%-3.35M
-3.24%46.88M
-115.41%-5.67M
498.96%25.32M
290.67%10.16M
-26.87%17.07M
2,524.77%48.45M
997.90%36.78M
-57.53%-6.35M
8.85%-5.33M
Effect of exchange rate changes
190.53%86K
712.50%49K
-2,300.00%-120K
-118.26%-21K
274.85%285K
-311.11%-95K
-101.94%-8K
-123.81%-5K
167.44%115K
-6.54%-163K
End cash Position
39.30%94.59M
92.14%97.86M
92.14%97.86M
632.17%103.65M
284.27%78.35M
162.41%67.91M
1,945.34%50.93M
1,945.34%50.93M
115.63%14.16M
93.23%20.39M
Free cash flow
26.93%-3.35M
-20.55%-23.61M
-149.41%-8.21M
51.28%-3.09M
-43.80%-7.72M
-0.20%-4.59M
-8.71%-19.58M
19.60%-3.29M
-57.53%-6.35M
8.18%-5.37M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
(Q1)Sep 30, 2025(FY)Jun 30, 2025(Q4)Jun 30, 2025(Q3)Mar 31, 2025(Q2)Dec 31, 2024(Q1)Sep 30, 2024(FY)Jun 30, 2024(Q4)Jun 30, 2024(Q3)Mar 31, 2024(Q2)Dec 31, 2023
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 26.93%-3.35M-21.57%-23.59M-149.41%-8.21M49.97%-3.09M-43.58%-7.7M-0.20%-4.59M-7.72%-19.4M19.58%-3.29M-53.09%-6.17M8.18%-5.37M
Net income from continuing operations -77.21%-8.97M-74.32%-37.92M-242.10%-16.15M-118.60%-9.35M-8.22%-7.36M15.03%-5.06M-11.19%-21.75M-1.27%-4.72M2.68%-4.28M-25.63%-6.8M
Depreciation and amortization 29.67%118K15.45%396K29.67%118K17.78%106K1.25%81K10.98%91K-9.97%343K8.33%91K-3.23%90K-21.57%80K
Other non cash items -------764K--0--0------------------------
Change In working capital 696.23%316K-332.45%-2.73M-738.89%-5.64M264.21%3.57M-148.13%-606K-104.40%-53K64.43%1.17M147.75%882K-1,185.50%-2.17M357.46%1.26M
-Change in receivables -86.73%30K211.93%197K83.52%-29K--0--0--226K-252.00%-176K---176K--0--0
-Change in prepaid assets 56.00%156K-117.21%-111K36.45%-258K-108.78%-18K-52.55%65K-85.90%100K255.80%645K-1.50%-406K151.00%205K-18.45%137K
-Change in payables and accrued expense 152.94%162K-350.92%-2.46M-441.53%-5.24M259.64%3.68M-150.13%-597K-154.45%-306K-31.47%980K87.07%1.53M-446.92%-2.31M318.93%1.19M
-Change in other current liabilities 56.16%-32K-29.45%-356K-55.71%-109K-44.93%-100K-7.25%-74K-8.96%-73K-9.13%-275K-9.38%-70K-9.52%-69K-9.52%-69K
Cash from discontinued investing activities
Operating cash flow 26.93%-3.35M-21.57%-23.59M-149.41%-8.21M49.97%-3.09M-43.58%-7.7M-0.20%-4.59M-7.72%-19.4M19.58%-3.29M-53.09%-6.17M8.18%-5.37M
Investing cash flow
Cash flow from continuing investing activities 89.94%-18K096.65%-6K-17,800.00%-179K0-179K
Net PPE purchase and sale ----89.94%-18K--096.65%-6K---------17,800.00%-179K--0---179K----
Cash from discontinued investing activities
Investing cash flow --089.94%-18K--096.65%-6K---12K--0-17,800.00%-179K--0---179K--0
Financing cash flow
Cash flow from continuing financing activities 03.61%70.49M-93.65%2.54M28.41M45,720.51%17.87M-22.43%21.66M324.78%68.03M40.07M039K
Net common stock issuance -----57.03%30.46M-100.00%1K-23,156.41%-9.07M45,730.77%17.87M-29.88%21.66M296.35%70.88M--40M---39K--39K
Proceeds from stock option exercised by employees --01,293.81%42.34M-12.80%2.62M----------21.66M--3.04M--3M--------
Net other financing activities ----60.64%-2.32M97.54%-72K---2.25M---------215.25%-5.89M---2.93M--0--0
Cash from discontinued financing activities
Financing cash flow --03.61%70.49M-93.65%2.54M--28.41M45,720.51%17.87M-22.43%21.66M324.78%68.03M--40.07M--0--39K
Net cash flow
Beginning cash position 92.14%97.86M1,945.34%50.93M632.17%103.65M284.27%78.35M162.41%67.91M1,945.34%50.93M-38.91%2.49M115.63%14.16M93.23%20.39M56.38%25.88M
Current changes in cash -119.63%-3.35M-3.24%46.88M-115.41%-5.67M498.96%25.32M290.67%10.16M-26.87%17.07M2,524.77%48.45M997.90%36.78M-57.53%-6.35M8.85%-5.33M
Effect of exchange rate changes 190.53%86K712.50%49K-2,300.00%-120K-118.26%-21K274.85%285K-311.11%-95K-101.94%-8K-123.81%-5K167.44%115K-6.54%-163K
End cash Position 39.30%94.59M92.14%97.86M92.14%97.86M632.17%103.65M284.27%78.35M162.41%67.91M1,945.34%50.93M1,945.34%50.93M115.63%14.16M93.23%20.39M
Free cash flow 26.93%-3.35M-20.55%-23.61M-149.41%-8.21M51.28%-3.09M-43.80%-7.72M-0.20%-4.59M-8.71%-19.58M19.60%-3.29M-57.53%-6.35M8.18%-5.37M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions --Unqualified Opinion--------Unqualified Opinion------
Market Insights
Nancy Pelosi Portfolio
No. Symbol % Chg
Sample Name
Sample Code
 +4.65%
Sample Name
Sample Code
 +4.15%
Sample Name
Sample Code
 +2.94%
4
Clean Energy Fuels
CLNE
+2.70%
5
American Express
AXP
+2.34%
China Concept Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +24.00%
Sample Name
Sample Code
 +7.99%
Sample Name
Sample Code
 +7.44%
4
KE Holdings
BEKE
+5.08%
5
NIO Inc
NIO
+4.61%
View More
The Fed Delivers Third Consecutive Rate Cut as Expected! How to Position for Year-End U.S. Equity Ma
On December 19, the Bank of Japan raised interest rates by 25 basis points as expected, in line with market forecasts. On the evening of Dec Show More
December FOMC Interest Rate Meeting
[Opportunity Express] MRVL Continues to Bet on Optical Interconnects: Is Now a Good Time to Enter the Market?

- No more -